Cargando…

Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies

Chagas disease (CD), caused by the intracellular protozoan Trypanosoma cruzi, is a parasitic illness endemic in Latin America. In the centennial after CD discovery by Carlos Chagas (1909), although it still represents an important public health problem in these affected areas, the existing chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soeiro, Maria de Nazaré C, de Castro, Solange Lisboa
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103897/ https://www.ncbi.nlm.nih.gov/pubmed/21629508 http://dx.doi.org/10.2174/1874104501105010021

Ejemplares similares

In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
por: Nesic de Freitas, Luca S. F., et al.
Publicado: (2023)

Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi
por: Salomão, Kelly, et al.
Publicado: (2011)

Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

Identification of Phenylpyrazolone Dimers as a New Class of Anti‐Trypanosoma cruzi Agents
por: Sijm, Maarten, et al.
Publicado: (2019)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018)

Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones
por: de Castro, Solange L., et al.
Publicado: (2011)

The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
por: Leite, Gabriela Rodrigues, et al.
Publicado: (2022)

Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022)

Antiparasitic Activity of Plumbago auriculata Extracts and Its Naphthoquinone Plumbagin against Trypanosoma cruzi
por: Peres, Raiza Brandão, et al.
Publicado: (2023)

Norfloxacin and N-Donor Mixed-Ligand Copper(II) Complexes: Synthesis, Albumin Interaction, and Anti-Trypanosoma cruzi Activity
por: Martins, Darliane A., et al.
Publicado: (2016)

In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
por: Canavaci, Adriana M. C., et al.
Publicado: (2010)

Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021)

In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection
por: da Silva, Cristiane França, et al.
Publicado: (2012)

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
por: Palos, Isidro, et al.
Publicado: (2017)

Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
por: Andriani, Grasiella, et al.
Publicado: (2011)

Overexpression of TcNTPDase-1 Gene Increases Infectivity in Mice Infected with Trypanosoma cruzi
por: da Silva-Gomes, Natália Lins, et al.
Publicado: (2022)

In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi
por: Peres, Raiza B., et al.
Publicado: (2021)

Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues
por: Salomão, Kelly, et al.
Publicado: (2013)

Anti-Trypanosoma cruzi inconclusive results in blood donor screening
por: Otani, Márcia Mitiko
Publicado: (2012)

High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
por: Alonso-Padilla, Julio, et al.
Publicado: (2014)

High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi
por: Bernatchez, Jean A., et al.
Publicado: (2020)

Nucleoside triphosphate diphosphohydrolase1 (TcNTPDase-1) gene expression is increased due to heat shock and in infective forms of Trypanosoma cruzi
por: Silva-Gomes, Natália Lins, et al.
Publicado: (2014)

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines
por: Menezes, Júlio César L., et al.
Publicado: (2014)

Correction: Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
Publicado: (2014)

In Silico Identification of New Targets for Diagnosis, Vaccine, and Drug Candidates against Trypanosoma cruzi
por: Trevisan, Rafael Obata, et al.
Publicado: (2020)

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells
por: Barbosa, Juliana Magalhães Chaves, et al.
Publicado: (2022)

In Vitro, In Vivo, and In Silico Studies of Cumanin Diacetate as a Potential Drug against Trypanosoma cruzi Infection
por: Sánchez Alberti, Andrés, et al.
Publicado: (2021)

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
por: Martinez-Peinado, Nieves, et al.
Publicado: (2020)

Temporizin and Temporizin-1 Peptides as Novel Candidates for Eliminating Trypanosoma cruzi
por: Souza, André L. A., et al.
Publicado: (2016)

Impact of autologous whole blood administration upon experimental mouse models of acute Trypanosoma cruzi infection
por: Philot Pavão, Beatriz, et al.
Publicado: (2018)

Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
por: da Silva, Cristiane França, et al.
Publicado: (2017)

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
por: Chen, Yen Ting, et al.
Publicado: (2010)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Assessing anti-T. cruzi candidates in vitro for sterile cidality
por: Cal, Monica, et al.
Publicado: (2016)

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
por: Cascabulho, Cynthia M, et al.
Publicado: (2020)

Unveiling the Trypanosoma cruzi Nuclear Proteome
por: dos Santos Júnior, Agenor de Castro Moreira, et al.
Publicado: (2015)

Repurposing of terconazole as an anti Trypanosoma cruzi agent
por: Reigada, Chantal, et al.
Publicado: (2019)

Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro
por: Bulhões Portapilla, Gisele, et al.
Publicado: (2019)

Simplifying screening for Trypanosoma cruzi in pregnant persons and their infants
por: Buekens, Pierre, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_irqo0cfruo2vtueoqr1gmua7qm